Streetbeat News

Products Services

SNOA

Sonoma Pharmaceuticals announced its next-generation solution for pulse lavage irrigation in the European Union. The new product aims to improve surgical outcomes and reduce complications.

Portfolio Pulse from Benzinga Newsdesk

June 09, 2023 | 7:01 pm

FRZA

Forza X1 shares are up following the announcement of an initial purchase order from OneWater Marine for 100 units of the company's 22-foot electric monohull boat, worth approximately $12 million.

Portfolio Pulse from Benzinga Newsdesk

June 09, 2023 | 6:53 pm

COPHF

MNMD

Creso Pharma (OTC:COPHF) signed a Letter of Intent (LOI) with Swiss pharmacy Apotheke Dr. Hysek AG for an exclusive partnership to import and distribute licensed MDMA and psilocybin products into Australia. The partnership follows Australia's new legal framework for psychedelic-assisted therapies, and Creso Pharma will provide import infrastructure through its subsidiary Health House International (HHI).

Portfolio Pulse from Lara Goldstein

June 09, 2023 | 6:27 pm

VOR

Vor Biopharma presented updated data from the VBP101 Phase 1/2a study of trem-cel in acute myeloid leukemia patients, showing early encouraging results. The FDA also cleared the company's IND application for VCAR33ALLO, a T-cell therapy derived from allogeneic healthy donors.

Portfolio Pulse from Vandana Singh

June 09, 2023 | 6:03 pm

NIO

NIO reported Q1 FY23 sales growth of 7.7% YoY to $1.56 billion, missing the consensus of $1.63 billion. EPS loss of $(0.36) beat the consensus loss of $(0.41). NIO ES6 ranked first in JD Power's 2023 China NEV Initial Quality Study. The company plans to launch NIO ET5 Touring on June 15 and upgrade its smart system Banyan to version 2.0.

Portfolio Pulse from Anusuya Lahiri

June 09, 2023 | 5:59 pm

IRON

Disc Medicine Inc (NASDAQ:IRON) presented positive preliminary findings from its Phase 2 BEACON trial of bitopertin for erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP) at the European Hematology Association 2023 Congress. The trial data showed consistent decreases in PPIX, significant increases in sunlight tolerance, and improvements in patient quality of life measures.

Portfolio Pulse from Vandana Singh

June 09, 2023 | 5:48 pm

PFE

TEVA

The FDA is seeking temporary suppliers of the cancer drug Methotrexate to address shortages. Pfizer (PFE) and Teva (TEVA) may be mentioned in the article.

Portfolio Pulse from Charles Gross

June 09, 2023 | 5:41 pm

KROS

Keros Therapeutics shares are trading lower following the announcement of data from its ongoing Phase 2 clinical trial of KER-050 and preclinical data evaluating ALK2 inhibition at the 28th Annual Congress of the European Hematology Association.

Portfolio Pulse from Benzinga Newsdesk

June 09, 2023 | 5:28 pm

ANGO

AngioDynamics announced the sale of its Dialysis product portfolio and BioSentry Tract Sealant System Biopsy product to Merit Medical Systems for $100 million, and also released its preliminary FY23 net sales guidance.

Portfolio Pulse from Benzinga Newsdesk

June 09, 2023 | 5:24 pm

GM

SPY

TSLA

Since Mary Barra became CEO of General Motors (GM) in 2014, the company has focused on transitioning to electric vehicles. A $1,000 investment in GM when Barra took over would be worth $1,213.02 today, a 21.3% return. In comparison, the same investment in the SPDR S&P 500 ETF (SPY) would have returned 176.1%, and in Tesla (TSLA), 2,167.4%.

Portfolio Pulse from Chris Katje

June 09, 2023 | 5:09 pm